Peter L. Salgo, MD: How do the biologics impact the asthma inflammatory pathway, and what is the targeted pathway for the treatment of asthma in the first place? Linda S. Cox, MD, FAAAAI, FACAAI, FACP ...

STANFORD, Calif. — Stanford University School of Medicine investigators have linked a master molecule of the immune system, gamma-interferon, to the pathology of asthma, in a study of mice. This ...

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a pilot study with Brooke Army ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Asthma is characterized by eosinophilic airway inflammation and elevated serum immunoglobulin E (IgE) levels. Due to these pathologic features, the foundation of asthma treatment has historically been ...

Shortness of breath, coughing, and respiratory infections. Childhood asthma, also known as asthmatic bronchitis, is one of the most common chronic diseases in children worldwide. But why does the ...

The investigational Bruton's tyrosine kinase (BTK) inhibitor rilzabrutinib was associated with numerical decreases in loss of asthma control events for patients with poorly controlled asthma, ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Todd A. Florin, MD ...

Childhood asthma was associated with difficulties with memory and other cognitive functions, according to an observational cohort study. In a longitudinal analysis, children with earlier onset of ...